Klingenberg R et al. |
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17761943
|
Hayashi H et al. |
FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19325137
|
Sanchez T et al. |
Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17431187
|
Keul P et al. |
The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17158351
|
Walter DH et al. |
Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17158356
|
Auge N et al. |
Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12482824
|
Jang C et al. |
Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19112163
|
Brinck JW et al. |
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966278
|
Daum G et al. |
Sphingosine 1-phosphate: a regulator of arterial lesions. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19592471
|
Tölle M et al. |
HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. |
2008 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:18483405
|
Wamhoff BR et al. |
Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. |
2008 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:18535287
|
Grabski AD et al. |
Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19608972
|
Smyth SS et al. |
Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. |
2014 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:24482375
|
Rikitake Y et al. |
Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11788469
|
Yoshida T et al. |
Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20431071
|
Frej C et al. |
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:28385702
|
McGuire PG et al. |
Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. |
2011 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:21940944
|
Denimal D et al. |
Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:28360087
|
Gaengel K et al. |
Endothelial-mural cell signaling in vascular development and angiogenesis. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19164813
|
Murohara T |
Printing a tissue: a new engineering strategy for cardiovascular regeneration. |
2010 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:20554948
|